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ABSTRACT
Objective Investigation of the reliability of the 
qualitative and semiquantitative scoring of nailfold 
videocapillaroscopy (NVC) assessment between two 
raters in a systemic sclerosis (SSc) cohort.
Methods Two raters from different centres blindly 
assessed the NVC images of 71 consecutive patients 
with SSc qualitatively as belonging to the scleroderma 
spectrum (SDS) category (‘early’, ‘active’, ‘late’ 
scleroderma pattern or ‘scleroderma-like’ pattern) 
or to the ‘normal’ category and semiquantitatively 
by calculating the mean score for capillary loss, 
giant capillaries, microhaemorrhages and capillary 
ramifi cations. Inter-rater/intrarater agreement was 
assessed by calculation of the proportion of agreement 
and by κ coeffi cients. Rater agreement of mean score 
values of hallmark parameters was assessed by intraclass 
correlation coeffi cients.
Results The inter-rater/intrarater proportion of 
agreement to qualitatively assess an image as belonging 
to the SDS category or not was 90% and 96%, whereas 
the agreement to distinguish between only ‘early’, 
‘active’ and ‘late’ scleroderma NVC patterns was 62% 
and 81%. The agreement of the semiquantitative scoring, 
as assessed by intraclass correlation coeffi cient, was 
0.96 and 0.95 for capillary loss, 0.84 and 0.95 for giant 
capillaries, 0.90 and 0.95 for microhaemorrhages and 
0.64 and 0.95 for capillary ramifi cations.
Conclusions This is the fi rst study to demonstrate 
reliability of the qualitative and semiquantitative NVC 
assessment in an SSc cohort between raters at different 
centres. Reliability of NVC assessment is essential for use 
of this tool in multicentre SSc trials.
INTRODUCTION
Systemic sclerosis (SSc) is a heterogeneous auto-
immune disorder characterised by vasculopathy 
as well as progressive ﬁ brosis of the skin and 
internal organs. When patients meet the American 
College of Rheumatology (ACR) criteria, they 
already have ‘clinically recognisable’ scleroderma 
(skin involvement) and can be classiﬁ ed into lim-
ited cutaneous SSc (LcSSc) and diffuse cutaneous 
SSc (DcSSc) subsets.1 2 To date, no treatment has 
been proved in a randomised controlled trial to 
halt the natural progression of the ‘clinically rec-
ognisable’ disease. Consequently, efforts are being 
made to study the disease ‘early’, before ‘clini-
cally recognisable’ disease and irreversible dam-
age have occurred.3 In 2001, LeRoy and Medsger 
proposed criteria for the ‘early’ diagnosis of SSc, 
with Raynaud’s phenomenon as the single major 
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criterion. These criteria incorporate SSc-speciﬁ c 
autoimmune antibodies and microvascular tech-
niques, more speciﬁ cally the ‘scleroderma-type’ 
changes on capillaroscopy.4 Like the ACR criteria, 
the LeRoy and Medsger criteria allow patients with 
‘clinically recognisable’ SSc (skin involvement), 
LcSSc and DcSSc to be included. In addition, 
however, they also allow patients to be included 
‘earlier’, before skin involvement has occurred. 
This third group of patients is classiﬁ ed as limited 
systemic sclerosis (LSSc), and is characterised by 
the presence of Raynaud’s phenomenon plus the 
presence of SSc-speciﬁ c autoimmune antibodies 
and/or the presence of typical ‘scleroderma-type’ 
abnormalities. The combination of Raynaud’s 
phenomenon with typical ‘scleroderma-type’ 
abnormalities as a criterion for ‘early’ diagnosis 
reﬂ ects the fact that Raynaud’s phenomenon often 
precedes the diagnosis of ‘clinically recognisable’ 
SSc, and the fact that the typical ‘scleroderma-
type’ abnormalities are speciﬁ c in distinguishing 
scleroderma spectrum (SDS) (SSc, mixed connec-
tive tissue disease (CTD), dermatomyositis, undif-
ferentiated CTD) from healthy controls or other 
CTDs. This diagnostic potential of capillaroscopy 
to distinguish SDS from other CTDs has already 
been established in several studies.5–10 Whether 
the capillaroscopic patterns of the SDS them-
selves are distinguishable is a matter of subjective 
opinion between experts. As yet, no large-scale 
blinded studies have been performed to resolve 
this question indisputably.11 12
The typical ‘scleroderma-type’ nailfold capil-
lary changes of the SDS were initially described 
by Maricq using the wide-ﬁ eld microscopy tech-
nique.13 14 Recently, Cutolo et al used a newer 
technique, nailfold videocapillaroscopy (NVC), 
to qualitatively assess the nailfolds of a cohort of 
patients fulﬁ lling the ACR criteria for SSc. This 
technique has the advantage that it consists of a 
handheld device which can be moved along the 
nailfold and which allows images of patients with 
SSc with severe ﬂ exion contractures to be taken. 
Cutolo et al classiﬁ ed the patterns of patients with 
SSc into ‘early’, ‘active’ and ‘late’ scleroderma 
patterns. To refer to the patterns of other SDS 
diseases, they used the terminology ‘scleroderma-
like’.15 In addition to the qualitative assessment, 
Cutolo et al also proposed the semiquantitative 
scoring of giant capillaries, capillary loss, micro-
haemorrhages and ramiﬁ cations.16–18 Both the 
qualitative and semiquantitative NVC assess-
ments are currently being practised in examining 
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clinical associations or as biomarkers.18 19 In order to use these 
assessments to study ‘early preclinical’ and ‘clinically recognis-
able’ disease uniformly in a number of centres, it is essential 
to have intrarater and inter-rater agreement between raters at 
different centres. This study investigates the reliability of the 
qualitative assessment and semiquantitative NVC scoring in an 
SSc cohort.
METHODS
Patients
Seventy-one consecutive patients (mean age 52±14 years) pre-
senting to the Scleroderma Clinic of Ghent University Hospital 
and fulﬁ lling the criteria for ‘early’ SSc according to LeRoy and 
Medsger were studied.4 Sixty-six were included on the basis of 
the capillaroscopy criterion as ascertained by MC. The other 
ﬁ ve patients all had SSc-speciﬁ c antibodies. The patients were 
subsequently divided into LSSc (no skin involvement), LcSSc or 
DcSSc (skin involvement) according to LeRoy et al.1 4
Nailfold videocapillaroscopy
Collection and blinding of nailfold videocapillaroscopic images
NVC was performed in all 71 patients, as described 
previously.18 Brieﬂ y, the nailfold of the second, third, fourth 
and ﬁ fth ﬁ ngers was examined bilaterally in each patient using 
an optical probe videocapillaroscope equipped with a ×200 
magniﬁ cation contact lens and connected to image analysis 
software (Videocap, DS MediGroup, Milan, Italy). Four con-
secutive ﬁ elds extending over 1 mm in the middle of the nail-
fold were studied per ﬁ nger. Two readers evaluated the same 
images in two different skilled centres, the Videocapillaroscopy 
Unit at the Academic Clinical Unit of Rheumatology at the 
University of Genova and at Ghent University Hospital. The 
images were made anonymous before being assessed by rater 
1 (CP, Genova) and rater 2 (VS, Ghent). To assess inter-rater 
reliability, rater 1 and rater 2 both read and scored all images 
once. To assess intrarater reliability, rater 2 read and scored all 
images twice. The minimum time interval between the two 
evaluations was 3 months.
Qualitative NVC assessment in the SSc cohort
The following capillaroscopic deﬁ nitions were used for the 
qualitative assessment. The ‘early’ NVC scleroderma pattern 
is deﬁ ned as the combination of few enlarged/giant capillaries, 
few capillary microhaemorrhages, a relatively well- preserved 
capillary distribution and no evident loss of capillaries 
(ﬁ gure 1A). The ‘active’ NVC scleroderma pattern involves 
frequent giant capillaries, frequent capillary microhaemor-
rhages, moderate loss of capillaries, mild disorganisation of the 
capillary architecture and absent or mild ramiﬁ ed capillaries 
(ﬁ gure 1B). The ‘late’ scleroderma NVC pattern includes irregu-
lar enlargement of the capillaries, few or absent giant capillar-
ies and microhaemorrhages, severe loss of capillaries with large 
avascular areas, disorganisation of the normal capillary array 
and ramiﬁ ed/bushy capillaries (ﬁ gure 1C). The ‘scleroderma-
like’ pattern is deﬁ ned as a capillary pattern showing mixed 
microvascular markers of the scleroderma capillary patterns, 
but not fully ﬁ tting the deﬁ nition for the single ‘early’, ‘active’ 
or ‘late’ scleroderma pattern.15–17
The SDS category is deﬁ ned as having either an ‘early’, ‘active’ 
or ‘late’ scleroderma pattern or a ‘scleroderma-like’ pattern. The 
‘normal’ category is deﬁ ned as a regular distribution of the capil-
laries without capillary loss and a morphology without speciﬁ c 
changes or non-speciﬁ c changes (ﬁ gure 1D).20
Semiquantitative NVC assessment in the SSc cohort
Semiquantitative scoring was performed as described 
 previously.18 The following hallmark parameters were counted 
over 32 ﬁ elds (4 ﬁ elds per ﬁ nger, ﬁ ngers 2–5 of each hand, 8 ﬁ n-
gers): total amount of capillaries (normal: 9/mm), giant capillar-
ies (homogeneously enlarged loops with a diameter >50 μm), 
microhaemorrhages (dark mass due to haemosiderin deposit) 
and ramiﬁ cations (branching, bushy or coiled capillaries, often 
originating from a single normal-sized capillary). The recently 
described semiquantitative rating scale (0 = no changes; 
1 = <33% of capillary alterations/reduction; 2 = 33–66% of 
 capillary alterations/reduction; 3 = >66% of capillary altera-
tions/reduction) was adopted.17 18 The mean score value for 
each capillaroscopic parameter was calculated.
Antibodies
Antibodies were detected by indirect immunoﬂ uorescence 
on Hep-2000 cells at a 1:40 serum dilution according to the 
manufacturer’s instructions (Immunoconcepts, Sacramento, 
California, USA). The SSc-speciﬁ c antibodies (anticentrom-
ere and antitopoisomerase) were detected by the INNO-LIA 
ANA Update (Innogenetics, Ghent, Belgium). Anti-RNA poly-
merase III was detected by ELISA (MBL International, Woburn, 
Massachusetts, USA) and anti-PM-Scl by immunodiffusion 
(Immunoconcepts).
Statistical methods
Inter-rater and intrarater agreement of dichotomous data was 
assessed by calculation of the proportion of agreement and by 
κ coefﬁ cients. When the proportion of agreement was relatively 
higher than the κ coefﬁ cient, explanation was sought by further 
investigating the separate indexes of agreement: positive and 
negative agreement. Rater agreement of mean score values of 
capillary loss, giant capillaries, microhaemorrhages and ramiﬁ -
cations was assessed by intraclass correlation coefﬁ cients. For 
Figure 1 Patterns of scleroderma and ‘normal’ pattern on nailfold 
videocapillaroscopy (×200 magnifi cation), qualitative assessment: (A) 
‘early’ scleroderma pattern, (B) ‘active’ scleroderma pattern, (C) ‘late’ 
scleroderma pattern; (D) ‘normal’ capillary pattern.
24_annrheumdis115568.indd   1093 5/6/2010   1:47:53 PM
Extended report
Ann Rheum Dis 2010;69:1092–1096. doi:10.1136/ard.2009.1155681094
The intrarater overall proportion of agreement in distinguish-
ing between the scleroderma patterns themselves was high 
(81%).
Concerning the reliability of the semiquantitative scoring, the 
inter-rater agreement is excellent for loss of capillaries, giant cap-
illaries, microhaemorrhages and fair for capillary ramiﬁ cations. 
The intrarater agreement is excellent for all mentioned hallmark 
parameters.
Several conclusions can be drawn from this study. First, assess-
ment of a capillaroscopic image as an ‘early’, ‘active’ or ‘late’ 
scleroderma pattern in an SSc cohort is reliable. This assessment 
may therefore be reliably used in multicentre trials. In this way, 
the recently published change of ‘late’ to ‘active’ capillaroscopic 
scleroderma pattern after stem cell transplantation and from a 
severe scleroderma pattern to almost ‘normal’ in mixed CTD is 
noteworthy.21 22 Second, the inter-rater and intrarater agreement 
of semiquantitative assessment of capillary loss, giant capillar-
ies and haemorrhages is high. Subsequently, these may have a 
role as a biomarker in therapeutic trials or in the investigation of 
prognostic associations.
Two points may be made concerning this study. First, when 
investigating the inter-rater reliability of qualitatively assess-
ing whether a capillaroscopic image belonged to the ‘SDS’ 
category or to the ‘normal’ category, the value (90%=‘high’) 
when tested with the overall proportion of agreement is higher 
than the value (0.6=‘good’) when tested with the κ statistic. 
Subsequent statistics to investigate and explain this difference 
in magnitude of value were performed. Next to the ‘overall’ 
proportion of agreement, the separate indexes of proportion-
ate agreement in the observers’ positive (positive proportion 
of agreement) and negative decisions (negative proportion of 
agreement) was investigated.23 The proportion of agreement 
in negative decisions between raters was substantially lower 
(63%) than the proportion of positive agreement (94%), and 
explains the relatively ‘lower’ value of κ than the value of 
‘overall’ proportion of agreement. Logical explanations for 
this lower proportion of agreement in negative decisions were 
made clear by qualitative re-assessment of the images in which 
the raters did not agree. As table 2 (rater 2, episode A) shows, 
there were ﬁ ve cases in which rater 1 assessed an image as not 
belonging to the SDS category while rater 2 did. Of these, four 
of the ﬁ ve ‘disagreements’ were caused by ‘information’ bias. 
These four images were characterised by the combination 
of ramiﬁ cations and capillary loss only. Ramiﬁ cations them-
selves may occur in healthy subjects and in CTDs ‘other than’ 
SDS.20 24 Logically, as rater 1 was not part of the study design, 
she marked these changes as ‘aspeciﬁ c’ ﬁ ndings (classiﬁ ed in 
the ‘normal’ category) while rater 2, who was informed that 
an SSc cohort was being investigated, consequently marked 
these cases either as ‘late’ or ‘scleroderma-like’ (classiﬁ ed in 
the ‘SDS’ category). The other case as well as the two cases 
scored by rater 2 as ‘not belonging to the SDS category’ and by 
normal distributions, means and SDs are reported; otherwise, 
medians and ranges are reported.
RESULTS
Characteristics of patients
The study group consisted of 71 patients (52 women, 19 men) 
who complied with the LeRoy and Medsger criteria (see table 
S1a in online supplement). The capillaroscopy criterion was met 
by 66 patients (93%) as ascertained by MC. The ﬁ ve patients 
(7%) who did not meet the capillaroscopic criterion all had 
SSc-speciﬁ c antibodies. Four were anticentromere positive and 
one was anti-RNA polymerase III positive. Forty-nine patients 
(69%) met the SSc-speciﬁ c autoantibodies criterion (see table 
S1b in online supplement). Twenty-two patients (31%) had no 
skin involvement (LSSc) and 49 (69%) had skin involvement (35 
LcSSc and 14 DcSSc).
Reliability of qualitative NVC assessment in patients with SSc
The qualitative assessment of the NVC images of the 71 patients 
is shown in table 1. The inter-rater proportion of agreement 
to assess an image as belonging to the SDS category or to the 
‘normal’ category was 90% (table 2; rater 2, episode A) with a 
κ coefﬁ cient of 0.6. The proportion of positive agreement was 
94% while the proportion of negative agreement was 63%. 
The intrarater proportion of agreement to assess an image as 
belonging to the SDS category or not was 96% (table 2; rater 
2, episode B) with a κ coefﬁ cient of 0.8. The inter-rater and 
intrarater proportions of agreement to distinguish between the 
‘early’, ‘active’ and ‘late’ scleroderma NVC patterns themselves 
were 62% (table 3; rater 2, episode A) and 81% (table 3; rater 2, 
episode B) with a κ coefﬁ cient of 0.5 and 0.7.
Reliability of the semiquantitative NVC assessment in patients 
with SSc
The reliability of the semiquantitative NVC assessment is shown 
in table 4. The inter-rater/intrarater agreement as assessed by 
intraclass correlation coefﬁ cient was 0.96/0.95 for capillary loss, 
0.84/0.95 for giant capillaries, 0.90/0.95 for microhaemorrhages 
and 0.64/0.95 for capillary ramiﬁ cations.
DISCUSSION
This is the ﬁ rst international two-centre study (Genova/Ghent) 
to investigate the reliability of qualitative and semiquantitative 
NVC assessment in a well-deﬁ ned SSc cohort.
The results of this study show that there is a high inter-rater 
proportion of overall agreement (90%) and a high intrarater 
proportion of overall agreement (96%) in qualitatively assess-
ing whether an image belongs to the ‘SDS’ category or to the 
‘normal’ category. When evaluating the reliability in distin-
guishing only between the ‘early’, ‘active’ and ‘late’ sclero-
derma patterns, the inter-rater agreement is substantial (62%). 
Table 1 Qualitative assessment of nailfold videocapillaroscopy images of 71 patients with systemic 
sclerosis
 
‘Normal’ 
category
Scleroderma 
pattern
‘Scleroderma-like’ 
pattern
Scleroderma pattern or 
‘scleroderma-like’ pattern
‘SDS’
category
Rater 1 11 35 25 0 60 (=35+25)
Rater 2, episode A 8 52 10 1 63 (=52+10+1)
Rater 2, episode B 9 58 2 2 62 (=58+2+2)
SDS, scleroderma spectrum.
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rater 1 as ‘belonging to the SDS category’ were likewise cases 
that were interpreted by one rater as ‘aspeciﬁ c changes’ and by 
the other as ‘active’ scleroderma pattern. These cases all had 
pathological haemorrhages and enlarged capillaries. The rater 
who interpreted the capillaries qualitatively as ‘enlarged’ clas-
siﬁ ed the image as ‘aspeciﬁ c ﬁ nding’ (classiﬁ ed in the ‘normal’ 
category) as the combination of pathological haemorrhages 
can appear in CTDs ‘other than’ SDS diseases, while the rater 
who interpreted them as giant capillaries classiﬁ ed them as 
‘active’ scleroderma pattern (classiﬁ ed in the ‘SDS’ category). 
These cases may be interpreted as true disagreements and 
marks the borders of qualitative assessment in which the 
interpretation of a capillary to be an ‘enlarged’ one or a ‘giant’ 
is made ‘on sight’ and not by quantitative measurement. 
Second, patients were included according to the LeRoy 
and Medsger criteria. The rationale behind this is that future 
multicentre studies will aim to include patients ‘earlier’ than 
when they present with ‘clinically recognisable’ disease. The 
authors decided to use the LeRoy and Medsger criteria to select 
Table 2 Inter-rater proportion of agreement in qualitative assessment 
of belonging to the ‘normal’ or ‘SDS’ category
 ‘Normal’ ‘SDS’ category Total
Rater 2, episode A*
 Rater 1
   ’Normal’ 6 5 11
   ’SDS’ category 2 58 60
   Total 8 63 71
Rater 2, episode B†
 Rater 2, episode A
   ’Normal’ 7 1 8
   ’SDS’ category 2 61 63
   Total 9 62 71
*Proportion of overall agreement: (58+6)/71=90%; proportion of positive agreement 
‘Yes’: 2.58/(63+60)=94%; proportion of negative agreement ‘No’: 2.6/(8+11)= 63%.
†Proportion of overall agreement: (61+7)/71=96%.
SDS, scleroderma spectrum.
Table 3 Inter-rater proportion of agreement in assessment between 
only ‘early’, ‘active’ and ‘late’ scleroderma patterns
 
‘No SSc-
specifi c’* ‘Early’ ‘Active’ ‘Late’ Total
Rater 2, episode A†
 Rater 1
   ’No SSc-specifi c’* 16 0 9 11 36
   ’Early’ 0 1 0 0 1
   ’Active’ 0 0 14 1 15
   ’Late’ 2 0 3 12 17
   Total 18 1 26 24 69‡
Rater 2, episode B§
 Rater 2, episode A
   ’No SSc-specifi c’* 11 0 2 5 18
   ’Early’ 0 1 0 0 1
   ’Active’ 0 0 22 4 26
   ’Late’ 0 0 2 22 24
   Total 11 1 26 31 69‡
*Category ‘No SSc-specifi c’ = ‘normal’ and ‘scleroderma-like’ (to be able to investigate 
the reliability between ‘only’ the ‘early’, ‘active’ and ‘late’ scleroderma patterns, the 
‘scleroderma-like’ pattern had to be categorised together with the ‘normal’ category).
†Proportion of overall agreement: (16+1+14+12)/69=43/69=62%.
‡Images of two patients were evaluated by rater 2, episode A as both ‘active’ and ‘late’ 
pattern. Consequently, these two pictures were left out the calculation.
§Proportion of overall agreement: (11+1+22+22)/69=56/69=81%.
SSc, systemic sclerosis.
an ‘early’ population as, at present, these criteria are the only 
ones that are validated in ‘early’ SSc.25 Consequently, SDS dis-
eases other than ‘clinically recognisable’ SSc may be included 
in this cohort. To acknowledge this, the study design allowed 
both raters to rate qualitatively one of the scleroderma patterns 
as ‘early’, ‘active’ or ‘late’ and also as ‘scleroderma-like’ pat-
tern. This is logical when investigating the reliability of raters 
in assessing whether an image belongs to the SDS category or 
to the ‘normal’ category. But it also has one drawback—spe-
ciﬁ cally (see table 3), when narrowing down the investigation 
to the reliability of ‘only’ the ‘early’, ‘active’ and ‘late’ sclero-
derma patterns, the ‘scleroderma-like’ pattern is classiﬁ ed into 
the ‘no SSc-speciﬁ c’ category with ‘normal’. This is illogical 
from a clinical point of view, but is the only way to evaluate 
the reliability of only the ‘early’, ‘active’ and ‘late’ scleroderma 
pattern, given the current study design. A possible option to 
overcome this drawback in future studies is only to allow 
raters in multicentre trials to rate as ‘early’, ‘active’ or ‘late’ 
scleroderma pattern. The alternative is that this terminology is 
described on a ‘clinically recognisable’ SSc cohort. Consensus 
will need to be sought in the setting up of multicentre studies, 
balancing the pros and cons of both options.
In short, in order to unravel the interaction between the 
different components of SSc (microvascular complications, 
SSc-speciﬁ c antibodies, internal organ involvement, disease 
severity and disease activity), large multicentre studies includ-
ing both ‘early’ and ‘clinically recognisable’ SSc are warranted. 
Capillaroscopy is a pivotal tool in SSc as it is a cornerstone for 
‘early’ diagnosis and it may have opportunities to be used as 
a biomarker. To be able to be uniformily used in multicentre 
studies, the reliability of NVC assessments ﬁ rst needs to be 
demonstrated. This is the ﬁ rst study to demonstrate the reli-
ability of the qualitative and semiquantitative NVC assessment 
in an SSc cohort.
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